A British participant in AstraZeneca’s coronavirus vaccine trial was diagnosed with a serious neurological disorder weeks after her second dose of the inoculation, an internal company document shows.
A previously healthy 37-year-old woman was hospitalized this month after receiving two injections of the pharmaceutical giant’s new vaccine, where it was determined she developed transverse myelitis, a rare neurological ailment caused by inflammation of the spine, according to an internal AstraZeneca safety report obtained by CNN.
Continue reading https://on.rt.com/aqkb